NovaDel Pharma has appointed Dr. Jan H. Egberts to the position of COO and to succeed Dr. Gary Shangold as president and CEO of NovaDel, effective December 23, 2005. Dr. Egberts joins NovaDel from Dynogen Pharmaceuticals, where he was the COO.
Pluristem Life Systems has appointed Zami Aberman as CEO. Shai Meretzki will resume his position as chief technology officer. Aberman operated within high-tech global companies in the fields of Automatic Optical Inspection, network security, Video over IP, software, chip design and robotic markets.
Assay Designs has appointed Gustavo Salem as president and CEO. Prior to joining Assay Designs, Salem held a variety of positions at Bio-Rad Laboratories in Hercules, California, including Division Manager of Protein Separations and Business Unit Manager for Biomaterials.
Genizon BioSciences has named Claude Lambert, CA, MBA, as vice-president and CFO and Dr. Renno Schuurmans as vice-president, business development, Europe.
Alastair McEwan has joined Cornerstone BioPharma as CFO. He has substantial experience in fund raising activities at all levels and has participated in two successful IPOs, most recently while at Inveresk Research Group, where he served as a member of the Group Executive Board and president of the Global Clinical division.
Questcor Pharmaceuticals named George Stuart as vice president of finance and CFO. Stuart joins Questcor from Xcel Pharmaceuticals, where he was vice president of finance, CFO and treasurer.
Oncolytics Biotech has named Karl Mettinger, MD, PhD, as chief medical officer. Prior to joining Oncolytics, he was senior vice president and chief medical officer with SuperGen.
Depomed has promoted Carl Pelzel to executive vice president and COO. Pelzel joined Depomed in June 2005 as vice president, marketing and commercial development.
IsoTis OrthoBiologics has appointed Kathryn (Kathe) E. Liljestrand as vice president marketing.
Pharmasset has appointed Lynn Hill as vice president, alliance & project management and Darryl Cleary, as vice president, manufacturing.
FoldRx has appointed Christoph Adams, PhD, as the company's first chief business officer. Dr. Adams comes to FoldRx having held senior-level management positions at Ciba-Geigy, Transkaryotic Therapies, and most recently ViaCell.
Tony Alvarez has been appointed to the newly created position of vice president, Commercial Operations, Schering-Plough in Japan. He joined Schering-Plough in 2003 as vice president, Global Business Planning and Services, following a career with Pharmacia.
AVANIR Pharmaceuticals has elected Craig A. Wheeler to the board of directors to fill a vacancy resulting from the resignation of Dennis J. Carlo, PhD.
Peter G. Schultz, PhD, has joined Nanosphere's board of directors.
Neil MacAllister has joined INC Research's board of directors.